Not exact matches
Swiss pharmaceutical giant Novartis has made waves with a drug pipeline that includes one of the
most talked - about experimental
cancer therapies in recent years — a treatment called Kymriah that reconfigures the body's own immune cells to become
aggressive blood -
cancer killers.
giant Novartis has made waves with a drug pipeline that includes one of the
most talked - about experimental
cancer therapies in recent years — a treatment called Kymriah that reconfigures the body's own immune cells to become
aggressive blood -
cancer killers.
It's an
aggressive cancer that attacks the
blood vessel cells and German shepherds are one of the breeds
most prone to the disease.